Ionetix Corp
Lansing, MI · CIK 0001672953 · Biotech · Public
Radiopharmaceuticals for diagnostic imaging and therapeutic treatment
ionetix.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $38M
- 3 Form D · Aug 2024
- 25 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $11,469,218 | |
| Private capital raised | Form D · SEC | $26,830,993 | |
| Private capital raised | Form D · SEC | $15,427,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2446 | Ribometrix LLC | — | $18M |
| 2447 | Spark2Flame, Inc | — | — |
| 2448 | Biohaven Pharmaceutical Holding Co Ltd. | — | $40M |
| 2449 | Ionetix Corp | — | $38M |
| 2450 | CALISTOGA PHARMACEUTICALS INC | — | $35M |
| 2451 | PROTEAN BIO INC. | — | — |
| 2452 | PALM THERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Douglas BootheDirector
- Carrie BuschExecutive Officer
- CARRIE BUSCHExecutive Officer
- Kevin CameronDirector · Executive Officer
- KEVIN CAMERONDirector · Executive Officer
- David EveExecutive Officer
- Nancy HargreavesExecutive Officer
- David MartinDirector
- Gregory MartinDirector
- DAVID MARTINDirector
- GREGORY MARTINDirector
- Phun PhieuExecutive Officer
- Anthony StagnoliaExecutive Officer
- Michael TarnockDirector
- MICHAEL TARNOCKDirector
- Michael TarnokDirector
- Gregory TaxinDirector
- GREGORY TAXINDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.